A detailed history of Soleus Capital Management, L.P. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 4,288,167 shares of EPIX stock, worth $6.9 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares
4,288,167
Previous 4,210,537 1.84%
Holding current value
$6.9 Million
Previous $22.1 Million 17.33%
% of portfolio
2.21%
Previous 2.24%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.45 - $7.1 $345,453 - $551,173
77,630 Added 1.84%
4,288,167 $26 Million
Q2 2024

Aug 14, 2024

BUY
$4.63 - $8.42 $2.88 Million - $5.23 Million
620,979 Added 17.3%
4,210,537 $22.1 Million
Q1 2024

May 15, 2024

SELL
$6.17 - $10.65 $4.55 Million - $7.86 Million
-738,064 Reduced 17.05%
3,589,558 $30.5 Million
Q4 2023

Feb 14, 2024

BUY
$2.74 - $7.35 $111,046 - $297,880
40,528 Added 0.95%
4,327,622 $28.6 Million
Q3 2023

Nov 14, 2023

BUY
$2.65 - $3.31 $225,250 - $281,350
85,000 Added 2.02%
4,287,094 $13.2 Million
Q2 2023

Aug 14, 2023

BUY
$2.6 - $3.34 $148,140 - $190,303
56,977 Added 1.37%
4,202,094 $11.3 Million
Q1 2023

May 15, 2023

BUY
$2.56 - $3.55 $705,856 - $978,823
275,725 Added 7.13%
4,145,117 $12.3 Million
Q4 2022

Feb 14, 2023

BUY
$1.5 - $4.82 $1.84 Million - $5.92 Million
1,228,853 Added 46.54%
3,869,392 $9.75 Million
Q3 2022

Nov 14, 2022

SELL
$1.75 - $3.44 $2.67 Million - $5.26 Million
-1,528,260 Reduced 36.66%
2,640,539 $4.81 Million
Q2 2022

Aug 15, 2022

SELL
$3.15 - $7.94 $173,250 - $436,700
-55,000 Reduced 1.3%
4,168,799 $13.1 Million
Q1 2022

May 16, 2022

BUY
$6.18 - $14.44 $4.32 Million - $10.1 Million
698,342 Added 19.81%
4,223,799 $26.1 Million
Q4 2021

Feb 14, 2022

BUY
$7.8 - $14.38 $5.13 Million - $9.45 Million
657,434 Added 22.92%
3,525,457 $50.1 Million
Q3 2021

Nov 15, 2021

BUY
$7.76 - $29.37 $4.89 Million - $18.5 Million
629,919 Added 28.15%
2,868,023 $22.9 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $34.28 $4.06 Million - $5.76 Million
168,052 Added 8.12%
2,238,104 $63.9 Million
Q1 2021

May 17, 2021

SELL
$11.61 - $32.08 $3.55 Million - $9.8 Million
-305,629 Reduced 12.86%
2,070,052 $60.1 Million
Q4 2020

Feb 16, 2021

BUY
$5.47 - $12.1 $3 Million - $6.64 Million
548,701 Added 30.03%
2,375,681 $28.3 Million
Q3 2020

Nov 13, 2020

SELL
$6.0 - $7.79 $1.53 Million - $1.99 Million
-255,205 Reduced 12.26%
1,826,980 $12.6 Million
Q2 2020

Aug 14, 2020

BUY
$3.71 - $6.2 $6,544 - $10,936
1,764 Added 0.08%
2,082,185 $12.9 Million
Q1 2020

May 15, 2020

BUY
$3.23 - $5.87 $1.44 Million - $2.62 Million
446,052 Added 27.29%
2,080,421 $8.32 Million
Q4 2019

Feb 14, 2020

BUY
$3.05 - $6.0 $4.98 Million - $9.81 Million
1,634,369 New
1,634,369 $8.99 Million

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $71M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.